NIAID Site Search

The NIAID strategic updated plan is structured around four strategic priorities that are critical to the development and evaluation of the knowledge and tools needed to end TB globally.

Last Reviewed: May 1, 2025

Tuan Manh Tran, M.D., Ph.D., of the Indiana University-Purdue University at Indianapolis K08 sample application

Last Reviewed: March 31, 2025

James M. Cherry, Ph.D. Chief, Research Technologies Branch Dr. Jim Cherry obtained his Ph.D. from the Catholic University of America in molecular biology with a concentration in bio-medical science. He earned an M.S. from Johns Hopkins University in molecular biology with a concentration in biotechnology. His bachelor’s degree is from Shepherd University with a major in biology and minor in

Last Reviewed: August 31, 2022

Last Reviewed: December 4, 2024

A list of contact information for the Respiratory Diseases Branch (RDB) at NIAID.

Last Reviewed: November 19, 2024

Sample application from Nicole Putnam, Ph.D., for National Research Service Award (NRSA) individual fellowship (F31) grants.

Last Reviewed: January 25, 2023

The scientific community can learn about NIAID funding opportunities, programs, and networks to further research and encourage collaboration as well as resources provided by NIAID to advance product development. Recent publications and ways to connect with other researchers are also available.

Last Reviewed: March 25, 2025

Last Reviewed: August 6, 2024

Last Reviewed: August 6, 2024

James M. Cherry, Ph.D. is the Chief of Operations of CHI. He leads a team of scientists who run this trans-NIH resource whose mission is to provide a collaborative hub of advanced translational immunology for NIH clinical and pre-clinical studies.

Last Reviewed: February 14, 2025

The Division of Microbiology and Infectious Diseases (DMID) within NIAID supports research to better understand, treat, and ultimately prevent infectious diseases caused by virtually all infectious agents, except HIV. DMID advances product development efforts through a number of ways, including funding opportunities and preclinical and clinical resources. For more information, please see DMID

Last Reviewed: January 31, 2024

A list of contact information for the various NIAID Division of AIDS (DAIDS) branches and programs.

Last Reviewed: April 25, 2025

Monitors new developments in the biotechnology industry Translates new technology applications into useful applications for biomedical research Develop project-specific applications using state-of-the-art technologies Technology Transfer and consultation Offer formal and informal training, support, and troubleshooting Evaluate new technologies applications Established a new bioinformatics

Last Reviewed: August 9, 2022

The mission of NIAID's strategic plan on tuberculosis (TB) research is to accelerate the end of the TB pandemic through research acceleration and innovation.

Last Reviewed: March 15, 2024

Office of Research on Women’s Health and NIH Support for Research on Women’s Health Report of the Advisory Committee on Research on Women’s Health: Fiscal Years 2019–2020 508-compliant PDF

Last Reviewed: March 8, 2022

Last Reviewed: January 28, 2021

NIAID Acting Director Dr. Hugh Auchincloss provided updates on HIV/AIDS, malaria, Ebola, a promising Marburg vaccine, universal flu vaccine efforts, non-viral asthma attacks, monoclonal antibodies to target Epstein-Barr virus, and human antibody response to vaccinations.

Published: February 15, 2023

NIAID Acting Director Dr. Hugh Auchincloss provided remarks on the Institute’s administrative, budget, and scientific news. He was followed by guest speaker Dr. Ted Pierson, Director of NIAID’s Vaccine Research Center, who discussed recent scientific advances and ongoing research priorities.

Published: October 4, 2023

Sample application from Rahul Raghavan, Ph.D., for Research Enhancement Award (R15) grant.

Last Reviewed: November 28, 2022

Sample grant summary statement from Stephen Dewhurst, Ph.D., for exploratory with possible transition to expanded development grant (R21/R33).

Last Reviewed: November 28, 2022

This document provides an overview of research and training programs opportunities for 2022-2023 available through the Division of Intramural Research.

Last Reviewed: November 3, 2022

This report provides a summary of the findings from the NIAID Expert Panel on Botulinum Neurotoxins Therapeutics 2004.

Last Reviewed: August 6, 2019

NIAID Process: Temperature excursions for products associated with Division of Microbiology and Infectious Diseases (DMID)- supported clinical trials.

Last Reviewed: August 6, 2019

Jordan Report: Accelerated Development of Vaccines (2007) from NIAID includes updates on vaccine research for specific infectious diseases.

Last Reviewed: August 6, 2019

NIAID's strategic plan on tuberculosis (TB) details priorities for building on research advances to end TB globally.

Last Reviewed: October 1, 2018